Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
about
Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient PopulationsCurrent and Future Considerations for the Treatment of Hospital-Acquired PneumoniaCeftobiprole medocaril in the treatment of hospital-acquired pneumonia[New antibacterial agents on the market and in the pipeline].Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013-2015Susceptibility to ceftobiprole of respiratory-tract pathogens collected in the United Kingdom and Ireland during 2014-2015
P2860
Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@ast
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@en
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@nl
type
label
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@ast
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@en
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@nl
prefLabel
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@ast
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@en
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@nl
P2860
P1433
P1476
Ceftobiprole medocaril: a revi ...... community-acquired pneumonia.
@en
P2093
Yahiya Y Syed
P2860
P2888
P304
P356
10.1007/S40265-014-0273-X
P577
2014-09-01T00:00:00Z
P6179
1013090604